UMSOM Endowed Professor and Renowned Neurologist Seemant Chaturvedi, MD, Receives Association of Indian Neurologists in America Lifetime Achievement Award

The Stewart J. Greenebaum Professor of Stroke Neurology, Dr. Chaturvedi is Internationally Recognized for His Research and Discoveries in the Fields of Stroke and Vascular Neurology

Seemant Chaturvedi, MD, the Stewart J. Greenebaum Endowed Professor of Stroke Neurology at the University of Maryland School of Medicine, was recently named the recipient of the Association of Indian Neurologists in America (AINA) Lifetime Achievement Award. This honor is one of the prestigious 2021 American Academy of Neurology Education Awards recognizing excellence in teaching and neurology education.

The AINA Lifetime Achievement Award annually recognizes a leader in neurology by his/her peers. The recipient is chosen based on his/her dedication to advancing the training of North American neurologists of Indian origin and promoting innovation and research in the field of neurology. The award is sponsored by the Association of Indian Neurologists in America Fund of the American Brain Foundation.

“I am very grateful to the selection committee for the honor of the Lifetime Achievement Award,” said Dr. Chaturvedi upon receiving notice of the award. “I have participated in AINA activities for more than 15 years and witnessing the growth of the organization has been very rewarding. I would like to acknowledge the support of my previous mentors and many esteemed professional colleagues, especially in the cerebrovascular community. Finally, I would like to thank my wife, children, and other close family members for their unwavering support and encouragement.”

Dr. Chaturvedi, who serves as the Stroke Program Director at the University of Maryland Medical System and as Vice-Chair for Strategic Operations in the Department of Neurology at the UMSOM, has led several clinical trials that have had a major impact on stroke prevention practices. His research interests include carotid and intracranial atherosclerosis, gender differences in stroke, and stroke in young adults.

Dr. Chaturvedi is board-certified in neurology and vascular neurology and a fellow of the American Academy of Neurology, American Heart Association, and American Neurological Association. A distinguished stroke neurologist, he serves on the editorial board of Stroke and Neurology and is an ad hoc reviewer for multiple other journals. Dr. Chaturvedi has provided several CME programs and has been course director for multiple programs. He has mentored numerous stroke fellows, including a number from India. He has served on the executive committee of AINA, and as president of that body. Dr. Chaturvedi is also an honorary member of the Indian Stroke Association and has multiple invited presentations around the world, including Asian American international conference in Goa, India; Indian Stroke Association meeting in Pune, India; and TS Srinivasan presentation in Bangalore and in Chennai, India.

About the Department of Neurology

The Department of Neurology is at the forefront of discovery in the battle to conquer a wide variety of neurological disorders and is one of the top 10 programs in the country in research funding for a variety of neurological diseases. Its faculty is working every day to make life easier for those dealing with Parkinson's, Alzheimer's, epilepsy, multiple sclerosis, strokes, and other debilitating diseases.

The Department’s Division of Stroke and Cerebrovascular Diseases provides comprehensive state-of-the-art management of patients with vascular causes of neurological disorders. Inpatient and outpatient stroke care is available. The Division also staffs the Brain Attack Team, a 24/7 service for acute stroke care. A variety of clinical research studies address acute stroke care as well as primary and secondary prevention strategies.

The University of Maryland is certified by MIEMSS and The Joint Commission as a Comprehensive Stroke Center in recognition that we are a regional center of excellence in stroke care and research. The Comprehensive Stroke Center is made up of a multidisciplinary team, that provides a continuum of care for patients from their acute presentation through their recovery in a rehabilitation setting.

About the University of Maryland School of Medicine

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 46 academic departments, centers, institutes, and programs, and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished two-time winner of the Albert E. Lasker Award in Medical Research.  With an operating budget of more than $1.2 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically based care for nearly 2 million patients each year. The School of Medicine has nearly $600 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding.  As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total population of nearly 9,000 faculty and staff, including 2,500 students, trainees, residents, and fellows. The combined School of Medicine and Medical System (“University of Maryland Medicine”) has an annual budget of over $6 billion and an economic impact of nearly $20 billion on the state and local community. The School of Medicine, which ranks as the 8th highest among public medical schools in research productivity (according to the Association of American Medical Colleges profile) is an innovator in translational medicine, with 606 active patents and 52 start-up companies.  In the latest U.S. News & World Report ranking of the Best Medical Schools, published in 2021, the UM School of Medicine is ranked #9 among the 92 public medical schools in the U.S., and in the top 15 percent (#27) of all 192 public and private U.S. medical schools.  The School of Medicine works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu